Basilea Pharmaceutica AG BPMUF
77.40 USD +1.15 (+1.51%)
At closeOct 30, 2026, 4:00 PM EDT
77.40 Day range 77.40
59.29 52-week range 77.40
- YTD
- +22.37%
- 1 year
- +29.06%
- Market cap
- 959.30M
- EPS (ttm)
- 5.05
- P/E ratio
- 15.33
- YTD return
- +22.37%
- 1-year return
- +29.06%
- Volume
- 100
- Avg volume
- 4
- Open
- 77.40
- Previous close
- 76.25
- Day's range
- 77.40 – 77.40
- 52-week range
- 59.29 – 77.40
1M 0.00 (0.00%)
News
Basilea Pharmaceutica AG (BPMUF) Q2 2026 Earnings Call Transcript 
Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Update 
Basilea receives further USD 13 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam 
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting 
Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420 
Basilea announces start of first‑in‑human study of novel antibiotic BAL2420 
Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam 
Basilea Pharmaceutica AG (BPMUF) Q4 2025 Earnings Call Transcript 
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance 
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Your note
Sign in to keep a note on BPMUF — it syncs with the Stock Master app.